Editor in Chief: Prof. Yasushi Shibata
Welcoming submissions for Volume 3 Issue 2
- About Journal
- Focus & Scope
- Editor in Chief
- Editorial Board
- Submit Manuscript
- Article Processing Charges
Clinical and translational research has been the major strength of any society and culture in today’s world. Since, ancient time’s human being is applying the knowledge gained from research studies over the years for attaining better outcomes in healthcare. Advances in Clinical and Translational Research (ACTR) is a scholarly open access journal that provides comprehensive coverage of recent discoveries and ongoing developments in the area of clinical and translational research. Articles are welcome in the form of original research, review articles, case reports, commentaries, mini-reviews etc. on emerging concepts and points of view.
All the manuscripts submitted to journal will be subjected to a thorough peer review by the experts in the field of the manuscript and the first decision will be provided to authors approximately within 28 days from the date of submission. Minimum two independent reviewer’s approval and an editor approval is taken into consideration for acceptance or rejection of a manuscript.
Articles published in advances in clinical and translational research will be distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium provided the original work is properly cited.
Focus & Scope
The Primary focus of advances in clinical and translational research is to deliver most exciting and novel information about scientific discoveries related to all aspects of research i.e, basic, preclinical, clinical, translational etc. and their outcomes. Advances in clinical and translational research journal cater to the requirements of the medical/clinical practitioners, researchers, lab professionals, students, academicians, and industries that are involved in research.
This journal will provide a comprehensive coverage on studies describing basic, preclinical, clinical, translational research in all the areas of internal medicine, surgery and medical sciences. The journal aims to cover all medical areas including epidemiology, clinical oncology, drug development, regenerative medicine, dentistry, palliative medicine, forensic medicine, pharmaceutics, pharmacology, etc.
Yasushi ShibataProfessor, Department of Neurosurgery
Mito Medical Center, University of Tsukuba
Mito Kyodo General Hospital, Japan
Dr. Shibata is serving as professor at Department of Neurosurgery, Mito Medical Center, University of Tsukuba, Japan. After graduating from University of Tsukuba, Tsukuba in 1988 he completed his residency program Neurosurgery, Anesthesiology and General Surgery at Tsukuba University Hospital and received Ph.D. from University of Tsukuba for a thesis entitled; “Neutron Capture Therapy with a new Boron-porphyrin compound in the rat 9L glioma model” in 1999. After receiving Ph.D., he conducted basic and clinical research at the Harvard Medical School, Boston, the Beth Israel Deaconess Medical Center, Boston, and the Massachusetts Institute of Technology, Cambridge, MA, USA. He published more than 200 peer reviewed manuscripts and more than 50 edited textbooks. He has received many research grants and awards. He is the on the board of the Japan Neurosurgical Society, The Japan Stroke Society, and The Japanese Headache Society.
Cerebrovascular Diseases; Head Injury; Neuroradiology; Headache; Brain Tumor; Spine; Epilepsy; Dementia; Neuroanatomy
Editor in Chief
Yasushi Shibata, Professor, Department of Neurosurgery, Mito Medical Center, University of Tsukuba, Mito Kyodo General Hospital, Japan, E-mail: firstname.lastname@example.org
Mutian Zhang, Chief Medical Physicist, Department of Radiation Oncology, Summa Health Cancer Institute, USA, E-mail: email@example.com
Mohammad Mehrmohammadi, Assistant Professor of Biomedical Engineering, Wayne State University, USA, E-mail: firstname.lastname@example.org
Shih-Shih Chen, Instructor, Karches Center for Oncology Research, The Feinstein Institute for Medical Research, Northwell Health, USA, E-mail: email@example.com
Ugo Rovigatti, Associate Professor of Molecular Biology, Department of Medicine, University of Florence, Italy, Email: firstname.lastname@example.org
- In Press
- Current Issue
Articles in Press (Volume 3 Issue 2)
Open Access Research Article
Reducing the missed opportunities and Increasing Human Papillomavirus Vaccination Rates among Early Adolescents with Low Socioeconomic Status
Authored by: Kimberly Pham, Somi Singh, Ryan Walters, Cristina Fernandez, Jayan Vasudevan, Cathy Hudson, Anthony Yaghmour, and Meera Varman
Current Issue (Volume 3, Issue 1)
Open Access Research Article
Echocardiographic Predictors of Cancer Therapeutics-Related Cardiac Dysfunction in Patients with Hematologic Malignancies
Authored by: Atai Watanabe, Naohide Yamashita, Toyotaka Kawamata, Kazuaki Yokoyama, Takaaki Konuma, Seiko Kato, Nobuhiro Ohno, Satoshi Takahashi, Kaoru Uchimaru, and Arinobu Tojo
We request you to submit the manuscript through submission form below. Note that all the fields marked* are mandatory. Please also include the full abstract that will help the reviewers to rapidly decide if your paper enters their domain of expertise or not. Also, we request you to submit appropriate keywords of the article to help the editors to assign your paper to the correct reviewers. Acknowledgement of the submitted manuscript will be mailed to corresponding author between 24-48 hours. If you feel any difficulty in submitting the manuscript through online submission system, you may email the manuscript directly to our editorial office at: email@example.com
Article Processing Charges
All the manuscripts submitted to Onjourn Publishers are assumed to be submitted under the open access publishing model. Being an open access publisher, we do not collect any subscription charges and allow the readers free access to all its articles. The manuscripts submitted to the journal will be peer reviewed similar way as in subscription model under the control of editorial board members. If the article is found to be acceptable for publishing in a particular journal then the author will be issued with an invoice for payment of article publishing charges. These charges are used as offset expenses for peer review management, journal production and online hosting and archiving. The article publishing charges for the articles accepted for publication in journals of Onjourn Publishers that are to be paid upon acceptance are
|Journal Name||Fee (GBP)|
|Advances in Clinical and Translational Research||1389|